Research ArticleResearch Article

Clinical Implications of HER-2 and P53 in Taxane-Based and Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

Xiaolan Wang, Fan Yao, Nan Liu, Yunfei Wu, Xinyu Zheng, Jiguang Li, Caigang Liu, Xueshan Qiu and Feng Jin
Chinese Journal of Clinical Oncology December 2008, 5 (6) 424-428; DOI: https://doi.org/10.1007/s11805-008-0424-5

Article Information

vol. 5 no. 6 424-428
DOI 
https://doi.org/10.1007/s11805-008-0424-5
Published By 
Cancer Biology & Medicine
History 
  • Received August 25, 2008
  • Accepted November 7, 2008
  • Published online December 1, 2008.
Copyright & Usage 
Copyright © 2008 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Xiaolan Wang1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Fan Yao1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Nan Liu2
  1. 2Department of Pathology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
  1. Yunfei Wu1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Xinyu Zheng1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Jiguang Li1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Caigang Liu1
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Xueshan Qiu2
  1. 2Department of Pathology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
  1. Feng Jin1⇑
  1. 1Department of Surgical Oncology Department of General Surgery;
  1. Correspondence to: Feng Jin E-mail: jinfeng66cn{at}hotmail.com
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords